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Abstract
Hedgehog (Hh) proteins control animal development and tissue homeostasis. They activate gene expression by regulating
processing, stability, and activation of Gli/Cubitus interruptus (Ci) transcription factors. Hh proteins are secreted and spread
through tissue, despite becoming covalently linked to sterol during processing. Multiple mechanisms have been proposed
to release Hh proteins in distinct forms; in Drosophila, lipoproteins facilitate long-range Hh mobilization but also contain
lipids that repress the pathway. Here, we show that mammalian lipoproteins have conserved roles in Sonic Hedgehog (Shh)
release and pathway repression. We demonstrate that lipoprotein-associated forms of Hh and Shh specifically block
lipoprotein-mediated pathway inhibition. We also identify a second conserved release form that is not sterol-modified and
can be released independently of lipoproteins (Hh-N*/Shh-N*). Lipoprotein-associated Hh/Shh and Hh-N*/Shh-N* have
complementary and synergistic functions. In Drosophila wing imaginal discs, lipoprotein-associated Hh increases the
amount of full-length Ci, but is insufficient for target gene activation. However, small amounts of non-sterol-modified Hh
synergize with lipoprotein-associated Hh to fully activate the pathway and allow target gene expression. The existence of
Hh secretion forms with distinct signaling activities suggests a novel mechanism for generating a diversity of Hh responses.
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Introduction
Hedgehog (Hh) family proteins are secreted signaling molecules
that control animal development and tissue homeostasis [1,2].
They are produced as precursors that are processed through
autocatalytic cleavage and sterol modification to generate the
active N-terminal signaling domain [3,4], which can be further
modified by palmitoylation [5]. Both lipid modifications influence
Hh signaling, but their precise function remains unclear [6].
Release of dually lipid-modified proteins from cell membranes
must involve specific secretion mechanisms. Work in different
systems has suggested several mechanisms to release Hh from
cellular membranes with its lipid moieties intact, including
exovesicles [7], multimers [8–11], and lipoproteins [12]. Although
the Drosophila lipoprotein Lipophorin (Lpp) promotes long-range
Hh spreading in the wing imaginal disc, Hh can still signal over
shorter distances in Lpp RNAi animals. Thus, wing discs may also
secrete Hh by Lpp-independent mechanisms.
In addition to mobilizing Hh, Lpp contains lipids that repress
the pathway in the absence of Hh [13]. When Hh is absent,
signaling by the 7-pass transmembrane protein Smoothened (Smo)
is catalytically repressed by the Hh receptor, Patched (Ptc) [14].
Ptc is thought to repress Smo by regulating access to lipophilic
ligands that alter Smo trafficking and activity [15–17]. Ptc can
mobilize Lpp sterols from endosomes, suggesting that Ptc may
modulate Smo activity, in part, by regulating access to inhibitory
Lpp lipids [13].
Smo signals by regulating processing of Gli family transcription
factors [Cubitus Interruptus (Ci) in Drosophila] [18,19]. When Smo
is inactive, these are processed to transcriptional repressors [20].
Active Smo stabilizes full-length Gli/Ci proteins, but to induce
target gene transcription, Gli/Ci activation requires additional
Smo-dependent events that are not well understood [21,22]. Lpp
specifically promotes degradation of full-length Ci155, but does not
influence its activation; upon Lpp RNAi, Ci155 accumulates, but
this does not suffice for target gene transcription [13].
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Thus far, the function of lipoproteins in the Hh pathway has
only been investigated in Drosophila. In this study, we demonstrate
conserved release mechanisms for Drosophila Hh and human Shh.
Both proteins can be secreted in two forms by many different cell
types—one is lipoprotein-associated and sterol-modified, the other
lacks sterol modification and can be released independently of
lipoproteins. Lipoprotein-associated forms of Hh and Shh are also
observed in systemic circulation of fruit flies and humans. The
lipoprotein-associated forms of Hh/Shh can alleviate the repres-
sive activity of lipoproteins on Hh signaling. Additional signals by
non-sterol-modified Hh proteins further activate the pathway to
effect target gene expression.
Results
Human and Drosophila Hh Proteins Are Secreted in Both
Lipoprotein-Associated and Lipoprotein-Free Forms
To investigate the secretion forms of mammalian Shh, we first
transfected HeLa cells with Shh, cultured them in serum-free
medium, and assayed Shh in supernatants after 48 h. Isopycnic
density centrifugation showed that all detectable Shh is present in
high-density fractions (Figure 1A). Thus, HeLa cells do not secrete
Shh on lipoproteins, or other low-density particles like exovesicles,
in the absence of extrinsically added factors. We then asked whether
HeLa cells might release Shh on exogenously added lipoproteins by
providing fetal bovine serum to Shh-transfected HeLa cells and
assaying Shh in density-fractionated supernatants after 48 h. These
supernatants still contain high-density Shh; however, an additional,
more abundant pool of Shh is found in fractions corresponding in
density to lipoproteins (Figure 1A). This increase in the level of
secreted Shh is not caused by increased Shh production (Figure
S1A), raising the possibility that serum lipoproteins facilitate the
release of Shh by HeLa cells. Transfecting HeLa cells with different
Shh lipid modification mutants shows that lipid modification is
essential for formation of the low-density secretion form; Shh-
NC24S, which lacks both cholesteryl and palmitoyl modification, is
present exclusively in high-density fractions (Figures 1B and S1B).
Thus, HeLa cells can secrete Shh in two forms, one of which
depends on extrinsic factors and lipid modification.
To ask whether serum increased Shh release or promoted its
stability in supernatants, we followed the accumulation of Shh in
supernatants over time. Low-density Shh is already detected in
supernatants 1 h after addition of fresh serum-containing medium
to Shh-transfected HeLa cells (Figure S1C). In contrast, high-
density Shh is only detected after 4 h. This suggests that serum
directly increases secretion of a low-density form of Shh.
To test directly whether low-density Shh corresponded to a
lipoprotein-associated form, we added specific human lipoprotein
classes to Shh-transfected HeLa cells—very low-density lipopro-
tein (VLDL), low-density lipoprotein (LDL), and high-density
lipoprotein (HDL). Western blotting cell supernatants showed that
VLDL, LDL, or HDL increases levels of Shh in supernatants
without affecting Shh levels in cell lysates (Figure 1C). In density
gradients, most Shh fractionates at a density characteristic of the
added lipoprotein (Figure 1D). To ask whether Shh bound directly
to lipoproteins, we immunoprecipitated lipoproteins from super-
natants containing either lipid-modified Shh or non-lipid-modified
Shh-NC24S. Shh, but not Shh-NC24S, is efficiently co-immunopre-
cipitated by antibodies to proteins that scaffold the major human
lipoproteins (Figures 1E and S1D). Thus, Shh associates directly
with all major human lipoprotein classes through its lipid moieties.
Secretion of Hh proteins by a variety of cancer types promotes
tumor growth [23]. To investigate the secretion forms of Shh
endogenously produced by cancer cells, we analyzed supernatants of
the pancreatic cancer cell line MIA PaCa-2 grown in serum-free
medium supplemented with VLDL, LDL, or HDL [24]. MIA PaCa-
2 cells produce much lower levels of Shh than transfected HeLa cells
(Figure S2A). However, similar to what we observed in HeLa cells,
addition of individual lipoprotein classes strongly increases the
amount of Shh present in supernatants (Figure 1F). Furthermore,
density gradients show that secreted Shh is present in fractions
characteristic of the added lipoprotein (Figures 1G and S2B). Very
minor amounts of Shh can also sometimes be detected in high-density
fractions. Thus, MIA PaCa-2 cells, which endogenously produce
Shh, can release it on the different human lipoprotein classes.
Shh is efficiently mobilized by three different lipoproteins of
widely different size and density, scaffolded by two distinct
apolipoproteins, suggesting broad specificity in the mechanisms
that promote Shh/lipoprotein association. To ask whether these
mechanisms might operate across phyla, we investigated whether
Drosophila Lpp could act as a carrier for human Shh. Indeed,
adding Drosophila hemolymph to serum-free medium induces
HeLa cells to release Shh that co-fractionates with Lpp
(Figure 1H). Conversely, Hh-expressing Drosophila S2 cells are
capable of secreted Hh in a low-density form when grown in the
presence of either Lpp or mammalian lipoproteins provided in
fetal bovine serum (Figure S2C,D). These data suggest that
conserved biophysical properties of lipoproteins, rather than
specific protein–protein interactions, promote their association
with Hh proteins. Interestingly, Drosophila S2 cells also produce a
high-density form of Hh similar to the high-density Shh observed
in HeLa cell supernatants.
Drosophila Hh Can Be Secreted Into the Hemolymph in
Both Lipoprotein-Associated and Lipoprotein-Free Forms
Since both human and Drosophila tissue culture cells release Hh
proteins in both lipoprotein-associated and non-associated forms,
Author Summary
Hedgehog (Hh) proteins are conserved secreted signaling
molecules that regulate embryonic development and adult
tissue homeostasis. Ectopic Hh signaling promotes tumor-
igenesis, and secretion of mammalian Sonic Hedgehog
(Shh) by many tumors supports their growth and survival.
As Hh proteins are covalently modified by sterol and
palmitate, specific mechanisms are required to release
them from cell membranes. Here, we show that different
fly and mammalian cell types, including Shh-dependent
cancer cells, release lipid-modified Hh/Shh on lipopro-
teins—the major lipid carriers in circulation. Perturbed
lipoprotein metabolism is a hallmark of metabolic syn-
drome, which is associated with many tissue pathologies
and an elevated cancer risk. We show that Drosophila and
mammalian lipoproteins act positively to mobilize lipid-
modified Hh proteins, but also contain lipids that repress
the pathway when Hh/Shh is absent. Association of Hh/
Shh with lipoproteins neutralizes their inhibitory effect in
both organisms. We also find that many cells release a
second form of Hh/Shh independently of lipoproteins that
lacks sterol modification. This form cannot overcome
lipoprotein-mediated repression but further activates the
pathway in the presence of lipoprotein-associated Hh/Shh.
The existence of multiple release forms with different
activities suggests novel conserved mechanisms for
generating diverse responses to Hh ligands. Our data also
suggest that perturbed Hh signaling could contribute to
human pathologies associated with lipoprotein dysfunc-
tion.
Lipoproteins in Drosophila Hh and Shh Signaling
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we wondered which forms might be found in vivo. Interestingly,
we noted that Hh proteins are present in animal circulation; Shh
in 100,000 g supernatants of human serum is present in density
gradient fractions that contain LDL/HDL (Figure S3A). Likewise,
Drosophila Hh is present in hemolymph, the insect body fluid
(Figure 2A). The Drosophila hemolymph represents a convenient
Figure 1. Shh is secreted in lipoprotein-associated and lipoprotein-free forms. (A) Density of human Shh secreted by HeLa cells in the absence
or presence of fetal bovine serum (FBS), analyzed by Optiprep density gradient centrifugation, and Western blotting (WB). HeLa cells transfected with
Shh were grown in serum-free medium or in the presence of 10% FBS, and equal volumes of supernatants analyzed. Colors indicate fractions
corresponding to bovine Very Low-, Low-, and High-Density Lipoproteins (VLDL, LDL, and HDL) [68]. (B) Density of non-lipid-modified Shh-NC24S,
analyzed by Optiprep density gradient centrifugation and WB. Supernatants were derived from HeLa cells transfected with Shh-NC24S and grown in the
presence of FBS. (C) Shh levels in cell lysates and supernatants derived fromHeLa cells transfectedwith Shh, grown in serum-free medium supplemented
with individual human lipoprotein classes. Equal protein amounts (cell lysates) or volumes (supernatants) were analyzed. (D) Density of Shh in HeLa cell
supernatants shown in (C), analyzed by Optiprep density gradient centrifugation and WB. Colors indicate fractions corresponding to human VLDL, LDL,
and HDL [43]. (E) Co-Immunoprecipitation (Co-IP) of secreted Shh with different lipoprotein classes, analyzed by WB. Supernatants were derived from
HeLa cells transfected with Shh or Shh-NC24S, grown in serum-free medium supplemented with individual human lipoproteins classes. (F) Shh levels in
supernatants derived fromMIA PaCa-2 cells grown in serum-free medium supplemented with individual human lipoprotein classes. Equal volumes were
used for WB. (G) Density of Shh inMIA PaCa-2 cell supernatants shown in (F), analyzed by Optiprep density gradient centrifugation andWB. (H) Density of
Shh in supernatants from Shh-expressing HeLa cells grown in serum-free medium supplemented with hemolymph from Drosophila larvae, analyzed by
Optiprep density gradient centrifugation and WB. Purple indicates fractions corresponding to Drosophila Lpp.
doi:10.1371/journal.pbio.1001505.g001
Figure 2. Drosophila Hh is secreted in Lpp-associated and Lpp-free forms. (A) Hh levels in hemolymph and whole extracts of wild-type and
hhTS larvae at restrictive temperature, analyzed by WB. Hemolymph loading control is a secreted GFP expressed from the tubulin promoter. (B)
Hemolymph Hh levels in wild-type and dispmutant larvae, analyzed by WB. Loading control is Cv-d. (C) Density of Hh in hemolymph of wild-type and
Lpp RNAi larvae, analyzed by Optiprep density gradient centrifugation and WB. Equal amounts of hemolymph (normalized by protein) were analyzed.
(D) Hemolymph Hh levels in larvae overexpressing Hh in imaginal discs with en105-GAL4, analyzed by WB. Loading control is Cv-d. (E) Density of
hemolymph Hh in larvae overexpressing Hh in imaginal discs, analyzed by Optiprep density gradient centrifugation and WB. (F) Density of Hh lipid
modification mutants (HhC85S, Hh-N, Hh-NC85S), secreted into the hemolymph from the fat body (FB) with lpp-GAL4, analyzed by Optiprep density
gradient centrifugation and WB.
doi:10.1371/journal.pbio.1001505.g002
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system to study in vivo Hh secretion, because the secreted form is
readily accessible and produced in the presence of all potentially
relevant extrinsic factors. Like Hh secretion in imaginal discs, Hh
secretion into circulation requires Dispatched (Disp) (Figure 2B)
[25]. However, imaginal discs are not a major source of
hemolymph Hh; RNAi-mediated Hh knock-down in discs does
not affect hemolymph Hh levels (Figure S3B). Neither is Hh
produced in the larval fat body (Figure S3C), the major source of
Drosophila lipoproteins [26]. The source and function of circulating
Hh will be reported elsewhere (Rodenfels et al., manuscript in
preparation). To ask whether hemolymph Hh circulated on
lipoproteins, we fractionated third instar larval hemolymph on
density gradients and probed for Hh and for apoLII, a scaffolding
apolipoprotein of Lpp. All detectable Hh co-fractionates with
apoLII, suggesting that hemolymph Hh is secreted on Lpp under
normal circumstances (Figures 2C and S3D).
Our observation that a variety of mammalian cell types can
secrete Shh on lipoproteins led us to wonder how general this
capacity might be in Drosophila tissues. Since the hemolymph
allows unambiguous detection of secreted Hh, we used the GAL4
system to induce ectopic expression of Hh in different tissues and
examined the secretion form present in the hemolymph. While
imaginal discs do not normally contribute to hemolymph Hh,
driving Hh overexpression in discs raises the level of Lpp-
associated Hh in circulation (Figure 2D,E). Thus, discs can secrete
Lpp-associated Hh, consistent with previous results [12]. Further-
more, the fat body and midgut can secrete high levels of Lpp-
associated Hh into the hemolymph in a Disp-dependent manner
(Figure S4A–D). The vast majority of overexpressed wild-type Hh
cofractionates with Lpp, even at the earliest time points after
inducing expression (Figure S4E). Thus, a wide variety of cell
types, including disc epithelial cells as well as unpolarized fat body
cells, can release Hh in association with lipoproteins.
To ask which lipid modifications were required for association
of Drosophila Hh with Lpp, we investigated Hh lipid modification
mutants—HhC85S, which lacks palmitate; Hh-N, which lacks
sterol; and Hh-NC85S, which lacks both modifications. We
ectopically expressed these different lipid mutant variants in the
fat body, using the fat body-specific driver lpp-GAL4 (Figure
S4F,G). Density gradients show that HhC85S is released entirely on
Lpp (Figure 2F). Hh-N is released predominantly on Lpp,
although small amounts are observed in high-density fractions.
In contrast, Hh-NC85S is present entirely in high-density fractions.
This indicates that most Hh secreted by the fat body is both
palmitoylated and sterol-modified and that either lipid modifica-
tion suffices for Lpp association.
To ask whether Lpp was needed for secretion of wild-type Hh to
circulation, we examined the effects of RNAi-mediated Lpp
knock-down. Analysis of hemolymph in density gradients revealed
that Hh is still secreted into the hemolymph when Lpp levels are
strongly reduced. While some Hh co-fractionates with residual
Lpp, most is present in dense fractions that do not contain apoLII,
a scaffolding protein of Lpp (Figure 2C). Reduced sterol levels
cannot account for the appearance of high-density Hh, because
dietary sterol depletion does not produce this phenotype (Figure
S3E,F). In addition to Lpp, Drosophila hemolymph contains two
minor lipoproteins of higher density, Lipid Transfer Particle (LTP)
and Crossveinless-d (Cv-d) [26]. However, most hemolymph Hh
secreted in Lpp RNAi larvae fractionates at even higher density
than LTP or Cv-d (Figure S3G). This high-density form of Hh
therefore does not correspond to LTP or Cv-d-associated Hh;
rather, it is a lipoprotein-independent form. Thus, Drosophila Hh
can be secreted into the hemolymph as both Lpp-associated Hh
and as a lipoprotein-independent form.
Lipoprotein-Free Hh and Shh Are Secreted as Non-Sterol-
Modified Dimers/Monomers
We wondered how Hh and Shh were secreted independently of
lipoproteins as high-density forms. Hh proteins have been
proposed to assemble into high molecular weight multimers that
interact via their lipid anchors [8–11]. Both Hh and Shh have also
been observed in monomeric forms. We therefore used gel
filtration chromatography to compare the sizes of different
secreted forms of Hh and Shh. Shh secreted in the absence of
lipoproteins elutes exclusively in low molecular weight fractions
consistent with Shh monomers (Figure 3A). This suggests that the
high-density form of Shh released by HeLa cells independently of
lipoproteins is not multimeric; rather, it corresponds to free Shh.
Shh from HeLa cells cultured in serum-containing medium is
found both in fractions consistent with monomers and in high
molecular weight fractions overlapping those containing the
apolipoprotein apoA1 (Figure 3A). Thus, high molecular weight
complexes may correspond entirely to lipoprotein-associated Shh.
To confirm that high-molecular weight pools correspond to the
low-density form of Shh, we pooled different sizing column
fractions and analyzed them by density gradient centrifugation.
Indeed, Shh in size ranges above 240 kDa fractionates entirely at
low density (Figure S5A). Conversely, Shh present in sizing
column fractions consistent with monomers is found in high-
density gradient fractions. Thus, HeLa cells produce at least two
forms of Shh, a high molecular weight, lipoprotein-associated form
and a monomeric form.
To characterize the size of the different secretion forms of
Drosophila Hh in hemolymph, we generated them in larger
amounts by overexpressing Hh in the fat body, alone or in
combination with induction of Lpp RNAi (Figure 3B,C). Gel
filtration chromatography revealed that in wild-type, Hh is present
in high molecular weight complexes that are the same size as Lpp
(Figure 3D). Examining these high molecular weight complexes in
density gradients confirms that they correspond to low-density Hh
(Figure S5B). Reducing Lpp levels causes the appearance of an
additional pool of Hh that fractionates near the 45 kDa standard
(Figures 3D and S5C). Thus, similar to HeLa cells, the Drosophila
fat body can secrete Hh into the hemolymph as a high molecular
weight Lpp-associated form, or as a low molecular weight complex
(possibly dimers) independently of Lpp.
It seemed unlikely for the normally lipid-modified Hh proteins
to be soluble as monomers or dimers. Therefore, we considered
the possibility that this pool of Hh/Shh lacked lipid modification.
To test this directly, we labeled Hh-producing S2 cells with 3H-
cholesterol under conditions where they produced similar amounts
of low-density and high-density forms. We subjected supernatants
to density gradient centrifugation and analyzed each fraction both
by Western blotting and in-gel fluorography. Western blotting
detects the Hh N-terminal domain in both low- and high-density
fractions, however only the low-density pool of Hh has incorpo-
rated radioactive cholesterol (Figure 3E). Thus, high-density Hh is
not modified by sterol.
Sterol modification can also be assayed by partitioning into
detergent and aqueous phases of Triton X-114 solutions [3,4]. In
this assay, sterol-modified Hh from low-density fractions of S2 cell
supernatants partitions predominantly into the detergent phase
(Figure 3F). In contrast, non-sterol-modified Hh in high-density
fractions partitions almost exclusively into the aqueous phase.
Triton X-114 phase partitioning of Hh/Shh variants genetically
engineered to lack different lipid moieties shows that sterol is
necessary and sufficient for partitioning into the detergent phase,
regardless of the presence of palmitate (Figure S5D,E). We
therefore used Triton X-114 partitioning to assess whether the
Lipoproteins in Drosophila Hh and Shh Signaling
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Figure 3. Molecular properties of lipoprotein-associated and lipoprotein-free Hh proteins. (A) Size of lipoprotein-associated and
lipoprotein-free Shh secreted from HeLa cells grown in the presence or absence of FBS. Supernatants were fractionated by gel filtration
chromatography on a Superdex 200 column, and fractions analyzed by WB. Molecular weight standards are indicated. Note that large mammalian
lipoproteins run in the void volume of these columns. (B) Hemolymph Hh levels in Drosophila larvae ectopically expressing Hh in the fat body, with or
without concomitant Lpp RNAi, analyzed by WB. (C) Density of hemolymph Hh produced in the fat body of control or Lpp RNAi larvae, analyzed by
Optiprep density gradient centrifugation and WB. (D) Size of Lpp-associated and Lpp-free hemolymph Hh ectopically produced in the fat body of
Lipoproteins in Drosophila Hh and Shh Signaling
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high-density forms of Hh/Shh produced by other cells were sterol-
modified. Shh secreted by HeLa cells in the absence of lipoproteins
partitions exclusively into the aqueous phase, suggesting that it is
not sterol-modified (Figure 3G). In contrast, Shh secreted in the
presence of lipoproteins partitions mostly into the detergent phase,
suggesting that lipoproteins allow the release of sterol-modified
Shh. The minority of Shh that partitions into the aqueous phase
also migrates slightly more slowly than detergent phase Shh,
consistent with the reduced mobility of Hh proteins that lack sterol
moieties [3,4]. To confirm that non-sterol-modified Shh in these
supernatants corresponds to the monomeric/high-density pool, we
subjected pools of size fractionated Shh to Triton X-114 phase
partitioning. Indeed, while the high molecular weight pool
partitions into the detergent phase, the low molecular weight pool
partitions into the aqueous phase (Figure S5A). Thus, while the
lipoprotein-associated pool of Shh is sterol-modified, the mono-
meric pool likely is not. Taken together, these data suggest that
HeLa cells release only monomeric, non-sterol-modified Hh in the
absence of lipoproteins, but can also release sterol-modified Shh
when lipoproteins are added.
To assess the sterol modification of Lpp-associated and high-
density Drosophila Hh forms secreted into the hemolymph, we
performed similar Triton X-114 phase partitioning experiments
on wild-type and Lpp RNAi hemolymph. Lpp-associated Hh
partitions to the detergent phase, indicating it is sterol-modified
(Figure 3H,I). In contrast, Hh isolated from Lpp RNAi hemo-
lymph, which comprises Lpp-associated and Lpp-free pools, is
found in both detergent and aqueous phases. Furthermore,
aqueous phase Hh migrates more slowly than detergent phase
Hh, similar to non-lipid-modified Hh mutants (Figure S5F). Thus,
Lpp-associated Hh present in the hemolymph is modified by sterol
and Lpp-free Hh likely is not.
Taken together, these data suggest that lipoproteins promote
release of sterol-modified Hh/Shh, whereas the Hh/Shh forms
that are secreted independently of lipoproteins appear to be non-
sterol-modified. The non-sterol-modified form is indistinguishable
in electrophoretic mobility and hydrophobicity from Hh-N/Shh-
N, which have been genetically engineered to lack sterol
modification. This suggests that their C-terminal sequence is very
close or identical to that of Hh-N/Shh-N; however, mass
spectrometric analysis will be required to determine it precisely.
We hereafter denote these endogenously produced Hh proteins
that lack sterol Hh-N*/Shh-N*.
Drosophila Imaginal Discs Release Both Lpp-Associated
Hh and Hh-N*
Although wing imaginal discs can release Hh on Lpp, our
previous results suggested that they also must release Hh in a Lpp-
independent form; Lpp RNAi does not prevent Hh secretion in
wing discs, but reduces its signaling range [12]. Because Shh can be
released on the different mammalian lipoprotein classes, we first
considered the possibility that other Drosophila lipoproteins might
mobilize Hh in wing discs. To more stringently remove lipoproteins,
we performed simultaneous RNAi against both Lpp and Micro-
somal Triglyceride Transfer Protein (MTP). MTP is required for
assembly of the two lipoproteins Lpp and LTP [26]. Blocking both
Lpp and LTP secretion causes defects similar to Lpp RNAi alone;
released Hh is detected over a shorter distance in the anterior
compartment, and its signaling range is correspondingly reduced
(Figure 4A). Furthermore, knock-down of either LTP or Cv-d alone
does not affect Hh signaling in the wing disc (Figure S6A,B). This
argues that Hh secreted by wing discs upon Lpp RNAi represents a
lipoprotein-independent form. We therefore considered whether
discs might normally release a non-sterol-modified form of Hh.
Although Hh overexpression in imaginal discs increases the
amount of Lpp-associated Hh in the hemolymph, it does not result in
detectable levels of high-density hemolymph Hh (Figure 2D).
Therefore, if discs do secrete this form of Hh, it may be more
tightly associated with cells or the extracellular matrix. We noted that
the N-terminal signaling domains of Drosophila and mammalian Hh
proteins have an unusually high pI (8.45–8.75) and thus should be
positively charged at physiological pH. To disrupt possible ionic
interactions between Hh proteins and imaginal disc tissue, we
dissociated disc cells under either mildly alkaline (pH 9) or high salt
(0.5 M NaCl) conditions. These conditions do not disrupt sterol
linkage; even pH 10 is insufficient to cleave the ester bond between
Hh and cholesterol (Figure S6C). To enrich for lowmolecular weight
forms of Hh, we prepared 100,000 g supernatants; a large fraction of
Lpp is pelleted at 100,000 g, along with small membrane fragments
and exovesicles (Figure 4B,C) [27]. Dissociation of discs at pH 9
dramatically increased recovery of Hh in 100,000 g supernatants,
compared to dissociation in PBS. Density gradient centrifugation of
these supernatants shows that most Hh is of high density, consistent
with depletion of membrane and Lpp-associated pools (Figure 4D).
Similarly, high salt conditions allow the recovery of high-density Hh
in 100,000 g supernatants (Figure S6D). Triton X-114 phase
partitioning indicates that high-density Hh is not sterol-modified
(Figure 4E). Smaller amounts of Hh are sometimes detectable in low-
density fractions, which also contain residual Lpp; Triton X-114
phase separation confirms that this pool of Hh is sterol-modified. On
sizing columns, high-density Hh from imaginal disc supernatants is
found in fractions consistent with monomers (Figure 4F). Taken
together, our data suggest that imaginal discs can release Hh in two
forms: one is sterol-modified and Lpp-associated, the other is neither
sterol-modified nor Lpp-associated. We obtained similar low- and
high-density pools of Hh from Drosophila embryos dissociated at
mildly basic pH or in high salt, suggesting that release of these two
Hh forms is widespread (Figure S7). The non-sterol-modified form
appears to bemonomeric. Note that the buffer conditions we used do
not disrupt lipoprotein particles, or the association of Hh with
lipoproteins (unpublished data). However, we cannot rule out that
these buffer conditions might disrupt complexes of Hh and other
proteins, if these required ionic interactions for their integrity.
Drosophila Lpp-Associated Hh Stabilizes Ci155 But Does
Not Activate Target Gene Expression
We wondered whether the signaling activity of Lpp-associated
Hh and Hh-N* might differ. To test this, we sought a method to
control or Lpp RNAi larvae, analyzed by gel filtration chromatography as described in (A). (E) Cholesterol modification status of low- and high-density
forms of Drosophila Hh. Supernatant from Hh-producing S2 cells grown in the presence of FBS and 3H-cholesterol was fractionated by KBr density
gradient centrifugation, and subsequently analyzed by both WB and in-gel fluorography. (F) Hydrophobicity of low- and high-density forms of Hh.
Supernatants from Hh-producing S2 cells grown in the presence of serum were fractionated by KBr density gradient centrifugation; fractions 1 and 8
were analyzed by Triton X-114 phase separation and WB. (G–I) Hydrophobicity of Shh and Hh produced in the presence or absence of lipoproteins,
assessed by Triton X-114 phase separation and WB. (G) Lysates and media from HeLa cells expressing Shh and grown in the presence or absence of
FBS. (H) Hemolymph from control and Lpp RNAi larvae. (I) Hemolymph from control and Lpp RNAi larvae ectopically producing Hh in the fat body.
Note that aqueous phase Hh/Shh has a lower electrophoretic mobility than detergent phase Hh/Shh.
doi:10.1371/journal.pbio.1001505.g003
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Figure 4. Imaginal discs produce Hh-N*. (A) Immunofluorescence (IF) of wing imaginal discs of MTP/Lpp co-RNAi larvae, stained for Hh, Lpp, and
Ptc. A denotes the anterior compartment, P the posterior compartment; yellow lines indicate the compartment boundary. Scale bar = 20 mm. (B)
Experimental scheme for the purification of Hh-N* from imaginal discs. Samples for experiments shown in (D–F) were prepared in 100 mM Na2CO3,
pH 9. (C) WB showing the levels of Hh recovered from imaginal discs with PBS or 100 mM Na2CO3, pH 9 after 16,000 g (S1) and 100,000 g (S2)
centrifugation steps. Sample amount in each lane corresponds approximately to the imaginal discs of two third instar larvae. (D) Density of Hh in
100,000 g supernatant of imaginal discs dissociated in pH 9 buffer, analyzed by KBr density gradient centrifugation and WB. Hh is present mainly in
high-density fractions; in some experiments, minor amounts of Hh can also be detected in low-density fractions. (E) Hydrophobicity of low-density
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expose wing discs specifically to each of these forms. To achieve
this, we ectopically produced different forms of Hh in the fat body
and assayed their activity in wing discs (Figure 5A). This method
has the advantage that the form and amount of Hh to which the
wing disc is exposed can be defined by analyzing the hemolymph.
We monitored pathway activity by three different methods. We
performed Western blotting against the Hh pathway components
Ci and Fused. During pathway activation, Fused becomes multiply
phosphorylated by different mechanisms; the extent of its
phosphorylation correlates with pathway activity and can be
monitored by electrophoretic mobility shifts [28]. We further used
immunostaining to detect the distribution of full-length Ci155 and
target gene expression (en, engrailed; col, collier; dpp, decapentaplegic) in
the wing pouch. Hh endogenously produced in the posterior
compartment of the wing disc signals to anterior cells close to the
compartment boundary. To distinguish the effects of Hh provided
exogenously through the hemolymph, we assayed signaling in
anterior regions far from the AP boundary, which are normally
not exposed to Hh. We also compared the relative sizes of the
anterior and posterior compartments; overexpressing Hh in the
wing disc causes anterior overgrowth, presumably because of
increased production of Dpp [29].
To ask whether raising the amount of circulating Lpp-associated
Hh could elevate Hh levels in wing discs, we used different GAL4
drivers to increase hemolymph Hh—lpp-GAL4, which increases
circulating Hh levels dramatically, and npc1b-GAL4, which
increases Hh levels more moderately (Figure S4A). The moderate
amounts of hemolymph Hh produced by npc1b-GAL4 do not
increase Hh staining or affect Hh signaling in the wing disc (Figure
S8A–C). Thus, the even lower amount of Hh normally present in
circulation is unlikely to influence the shape of the wing disc Hh
gradient. In contrast, the much higher circulating Lpp-associated
Hh levels induced by lpp-GAL4 raise Hh staining throughout the
anterior compartment of the wing disc to levels normally observed
only near the AP boundary (Figure 5B,C). Thus, this condition
provides Lpp-associated Hh to the whole wing disc in relevant
amounts, allowing us to specifically assess its signaling activity.
Lpp-associated Hh stabilizes Smo (Figure S8D) and Ci155
(Figure 5B,D) throughout the wing pouch and increases
phosphorylation of Fused (Figure 5E). However, Lpp-associated
Hh does not increase transcription of dpp (Figure 5G), en (Figure
S8F,G), or col (Figure 6G,H), and causes barely detectable anterior
overgrowth (Figure 5H). This is surprising, because Hh present at
similar levels in the normal wing disc gradient activates these
target genes. Western blotting reveals that Lpp-associated Hh,
although it increases the amount of full-length Ci155, does not
reduce levels of the repressor Ci75 (Figures 5F and S8D). Thus,
Lpp-associated Hh has only a subset of the activities of Hh
normally released by wing disc cells. The effects of Lpp-associated
Hh are remarkably similar to those of Lpp RNAi—increased
phosphorylation of Fused and stabilization of Ci155 without
reduction of Ci75 or activation of target genes (Figure 5) [13].
This suggests that Lpp-associated Hh does not promote Ci155
activation or block its processing to the repressor form; rather, it
specifically stabilizes inactive full-length Ci155. We note that these
high levels of Lpp-associated Hh actually repress en and col
expression in the anterior compartment (Figures 6G,H and
S8F,G), suggesting that they compete with Hh produced locally
by posterior compartment cells. This is consistent with the idea
that wing discs normally make not only Lpp-associated Hh but
also a Lpp-independent form.
Drosophila Hh-N* and Hh-N Can Activate Target Gene
Expression
As the effect of Lpp-associated Hh on the Hh pathway is
confined to Ci155 stabilization, we wondered whether Hh-N*,
which is endogenously produced by imaginal discs, might exert
additional effects leading to target gene transcription. To address
this, we reduced Lpp-mediated Ci155 degradation and simulta-
neously exposed wing discs to additional Hh-N* provided by the
hemolymph. We accomplished this by concomitant expression of
Lpp RNAi and Hh in the fat body. Under these conditions, the
hemolymph contains moderate levels of Hh-N*; some Hh is also
detected on residual Lpp (Figure 3C). The total amount of Hh
present in the hemolymph is less than when Hh is ectopically
produced by otherwise normal fat bodies (Figure 3B), and it
accumulates at lower levels in the wing disc (Figure S9A,B).
However, Hh produced by the fat body in Lpp RNAi animals
induces ectopic expression of dpp in some regions of the wing disc
(Figure 5G) and causes strong anterior overgrowth (Figure 5H).
This suggests that Hh-N* can induce transcription of target genes,
at least when Ci155 is stabilized by Lpp RNAi. The fact that even
larger amounts of Lpp-associated Hh do not produce these effects
suggests that Hh-N* is either more potent or that its signaling
activity is different.
Since our biochemical data indicated that Hh-N* lacked sterol
modification, we wondered whether its activity might be mimicked
by Hh-N, which is genetically engineered to lack sterol modifica-
tion. The signaling activity of Hh-N/Shh-N has been investigated
in different systems including wing discs. Their activity compared
to wild-type proteins has been controversial—they have been
proposed to signal over both longer and shorter ranges than the
wild-type form [10,30,31]. However, it has been difficult to
determine the concentration of secreted Hh-N or sterol-modified
Hh to which tissue is exposed in vivo. To compare the signaling
activity of Hh-N to that of wild-type Hh at definable concentra-
tions, we expressed each protein in the fat body and first compared
their levels in the hemolymph. We used two different Hh-N
expression constructs (Hh-NMed and Hh-NLow) to drive Hh-N
expression. Both produce much lower concentrations of circulat-
ing Hh than the wild-type Hh expression construct (Figure 6A).
The weak Hh-NLow does not increase wing disc Hh staining
detectably when expressed in the fat body. Driving Hh-NMed in
the fat body does increase Hh levels in the wing disc, but to a
much lesser extent than expression of wild-type Hh (Figures 6E
and S10A,B).
We next compared how these defined amounts of Hh-N and
wild-type Hh derived from the fat body influenced signaling in the
wing disc. In striking contrast to wild-type Lpp-associated Hh,
which only causes Ci155 stabilization and a moderate increase in
Fused phosphorylation, these moderate levels of Hh-N produced
from Hh-NMed elicit the full spectrum of Hh responses; Fused is
extensively phosphorylated (Figure 6B), Ci75 levels are reduced
(Figures 6C and S10E), and Ci155 accumulates (Figure 6F,H).
Furthermore, target gene expression is activated throughout the
wing pouch (Figures 6G,H and S10A–C), and wing discs strongly
overgrow anteriorly (Figure 6D). The minor amounts of Hh-N
produced by Hh-NLow do not affect target gene activation.
and high-density Hh recovered from imaginal discs, analyzed by Triton X-114 phase separation and WB. (F) Size of high-density Hh recovered from
imaginal discs, analyzed by gel filtration chromatography and WB.
doi:10.1371/journal.pbio.1001505.g004
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However, when combined with wild-type Hh, they suffice to
extensively phosphorylate Fused (Figure 6B), deplete Ci75
(Figures 6C and S10F), activate target gene expression
(Figures 6G,H and S10G), and cause anterior overgrowth
(Figure 6D). Thus, Hh-N has a qualitatively different signaling
activity from wild-type Hh and can activate transcription of target
genes. A possible explanation for this is that Hh-N has features of
both wild-type Lpp-associated Hh and Hh-N*. It can associate
with Lpp, but lacks sterol modification and is partially released as a
high-density form. This raises the possibility that the combination
of these Hh forms is more powerful that either one alone.
Consistently, even otherwise inactive amounts of Hh-N suffice to
induce target gene expression if Ci155 is stabilized by wild-type
Lpp-associated Hh.
Lipoprotein-Associated Shh Reverses Pathway Inhibition
by Mammalian Lipoproteins
To investigate the signaling abilities of lipoprotein-associated
Shh and Shh-N*, we assayed their activities in Shh-LIGHT2 cells.
These cells harbor a luciferase reporter sensitive to Gli repressors
and activators [32,33]. We isolated lipoprotein-associated Shh
from supernatants of cells grown with serum by density
centrifugation. We prepared Shh-N* from supernatants of cells
grown in serum-free medium. We added increasing amounts of
either lipoprotein-associated Shh (Figure 7A) or Shh-N*
(Figure 7B) to Shh-LIGHT2 cells in serum-free conditions. For
lipoprotein-associated Shh, lipoprotein concentrations were kept
constant; only the fraction of lipoproteins carrying Shh was varied.
Both forms of Shh increase reporter activity in a concentration-
dependent fashion (Figure 7A,B). To ask whether lipoproteins
repress signaling by Shh-N*, we added both Shh-N* and purified
lipoproteins to Shh-LIGHT2 cells. Under these conditions, the
vast majority of Shh-N* remains unassociated with lipoproteins
(Figure S11A). Reporter activation by Shh-N* is strongly reduced
by lipoproteins in a dose-dependent manner (Figure S11B). In
contrast, even much higher amounts of lipoproteins do not repress
signaling by lipoprotein-associated Shh (Figures 7C and S11B).
Thus, mammalian lipoproteins repress signaling by lipoprotein-
free Shh-N*. However, binding of Shh to lipoproteins blocks their
inhibitory action—similar to the situation in Drosophila.
This similarity led us to wonder whether the inhibitory
molecules in lipoproteins were conserved. To test this, we asked
whether Drosophila Lpp could inhibit signaling in Shh-LIGHT2
cells. Indeed, Lpp strongly represses signaling by Shh-N*. In
contrast, Shh associated with Lpp signals efficiently (Figure 7D).
Thus, the inhibitory activity of lipoproteins on the Hh pathway is
conserved between Drosophila and mammals. Lipoprotein-associ-
ated Shh can overcome this inhibition, but Shh-N* cannot.
We wondered whether Shh-N* might signal more efficiently if
lipoprotein-mediated inhibition was blocked by lipoprotein-asso-
ciated Shh. We therefore assayed their activity in Shh-LIGHT2
cells alone and in combination. We chose concentrations of Shh
either in the linear response range or at saturation concentrations
(see Figure 7A,B). While Shh-N* signals only weakly in the
presence of lipoproteins, adding Shh-N* together with lipoprotein-
associated Shh causes a more than additive increase in reporter
activity at nonsaturating concentrations of Shh (Figure 7E). This
suggests that lipoprotein-associated Shh and Shh-N* may increase
pathway activity synergistically.
Discussion
A variety of different mechanisms have been proposed to
account for the release and spread of dually lipid-modified Hh
proteins [6,34]. In mammalian systems, secreted Hh proteins have
been observed in high-molecular weight complexes and on
exovesicles [7–11]. Monomeric forms have also been detected,
but how a doubly lipid-modified protein could remain soluble as a
monomer has never been explained. In Drosophila, association with
the insect lipoprotein Lpp promotes long-range Hh signaling, but
Lpp knock-down experiments suggested that at least one shorter
range form must also exist [12]. This apparent diversity in release
mechanisms raises the question of how different forms of Hh act
on cells. In this work, we establish that mammalian Shh can be
released on lipoproteins, like its Drosophila counterpart, and we
identify and biochemically characterize a second conserved release
form that is monomeric/dimeric and non-sterol-modified (Hh-
N*/Shh-N*). We use both mammalian signaling assays and in vivo
experiments in Drosophila to distinguish their effects on the Hh
pathway and show that they signal synergistically.
Our studies of lipoprotein-mediated release of Shh were
facilitated by the use of cell types (HeLa and Mia-PaCa2) that
rely on extrinsic factors (in this case lipoproteins) to release sterol-
modified Shh. Interestingly, it was recently shown that extrinsic
addition of Scube to tissue culture cells also promotes release of
lipid-modified Shh [35,36]. Together, these studies highlight the
emerging importance of non-autonomously acting factors in the
release of sterol-modified Hh proteins. HEK293 and Bosc23 cells,
which have often been used to study Shh release mechanisms, are
able to release some sterol-modified Shh even in defined serum-
free media [11]. It would be interesting to ask whether these
differences might be accounted for by endogenous production of
factors like Scube or apolipoproteins.
Conserved Functions for Lipoproteins in the Hh Pathway
Our work in tissue culture shows that an evolutionarily
conserved feature of lipoproteins is their ability not only to
mobilize Hh proteins, but also to repress pathway activity. A
unique function of lipoprotein-associated forms of Hh is to reverse
this pathway inhibition. To what extent are lipoproteins important
for the in vivo function of mammalian Hh proteins? Genetic
studies have not highlighted obvious links between mammalian
lipoprotein metabolism and the Hh pathway. However, it has been
noted that loss of apoB-containing lipoproteins does produce a
subset of phenotypes similar to those of Hh loss of function
[37,38]. Knockouts of individual members of the large family of
apoA-like apolipoproteins are viable [39,40]. However, since we
have shown that Shh can be released on all human lipoprotein
Figure 5. Signaling properties of Lpp-associated Hh and Hh-N*. (A) Cartoon depicting the fat body to wing disc signaling assay of secreted
Hh. (B) IF of wing discs from larvae secreting Hh from the fat body, and Lpp RNAi larvae, stained for Hh, Ci155, and Lpp. Scale bar = 50 mm. In all wing
discs, A denotes the anterior compartment, P the posterior compartment; yellow lines indicate the compartment boundary. Scale bar = 50 mm. (C and
D) Quantification of (C) Hh and (D) Ci155 staining of wing discs shown in (B). Translucent lines indicate 6SD (n= 12). (E) Phosphorylation status of
Fused in wing discs of larvae secreting Hh from the fat body and Lpp RNAi larvae, analyzed by WB. (F) Ci75 repressor levels in wing discs of larvae
secreting Hh from the fat body, and Lpp RNAi larvae, analyzed by WB. (G) IF of wing discs from larvae secreting Hh or Hh-N* from the fat body,
stained for dppLacZ and, to mark cell boundaries, with phalloidin. Hh-N* was generated by expressing Hh in the fat body of Lpp RNAi animals. Scale
bar = 50 mm. (H) Wing disc anterior to posterior compartment ratio of larvae secreting Hh or Hh-N* from the fat body and Lpp RNAi larvae. Error bars
indicate 6 SEM (n= 20). ***p,0.0005; ****p,0.00005.
doi:10.1371/journal.pbio.1001505.g005
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Figure 6. Signaling properties of Hh-N. (A) Hemolymph Hh levels of larvae secreting Hh, Hh-NMed, Hh-NLow, or Hh+Hh-NLow from the fat body,
analyzed by WB. (B) Phosphorylation status of Fused in wing discs from larvae secreting different combinations of Hh and Hh-N from the fat body,
analyzed by WB. (C) Levels of Ci repressor (Ci75) and Ci155 (full-length) in wing discs of larvae secreting different combinations of Hh and Hh-N from
the fat body, analyzed by WB. (D) Wing disc anterior to posterior compartment ratio of larvae secreting different combinations of Hh and Hh-N from
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classes, redundancy might make a requirement for lipoproteins
hard to identify genetically. Furthermore, phenotypic analysis may
be confounded by the fact that lipoproteins exert both positive and
negative effects on the Hh pathway.
Many different tissues produce lipoproteins and they are
abundant in circulation and interstitial fluids [41–43]. While
access to large lipoproteins such as VLDL may be limited by the
permeability of the vasculature in some tissues, HDL is abundant
in interstitial fluid. Even before development of the embryonic
vasculature is complete, apoA1 can be readily detected in mouse
limb buds (M. Swierczynska and S. Eaton, unpublished
observation). Thus, it will be interesting to assess the relative
contributions of different lipoproteins to Shh release and signaling
in vivo during development and adult tissue homeostasis. Many
tumors secrete Hh proteins, which they require for growth
[23,44]. Interestingly, lipoprotein levels are unbalanced in
metabolic syndrome, which is associated with an increased risk
of cancer development. Tumors promote both angiogenesis and
vascular permeability and should have access to a broad range of
lipoproteins [45]. Thus, our observation that lipoproteins
enhance Shh release by the pancreatic cancer cell line Mia-
PaCa2 [24] may be relevant to a broad variety of Shh-secreting
tumors in vivo.
In addition to mobilizing Hh proteins locally, our work
suggests that lipoproteins may also function to carry them into
systemic circulation. While we do not address the physiological
role of circulating Hh here, we demonstrate that Drosophila Hh
produced in one organ can signal to another in an endocrine
manner. Hh signaling is known to influence lipid metabolism in
both mammals and flies [46–48], and Hh associated with
circulating lipoproteins may be important in this regard.
Perturbed lipoprotein metabolism is a widespread phenomenon
in modern society and is associated with a wide variety of
different tissue pathologies [49]. Our results raise the possibility
that lipoprotein dysfunction might cause disease in part by
altering Hh signaling.
Release of Hh Proteins as Non-Sterol-Modified Forms
Our work also demonstrates that Hh proteins can be released
independently of lipoproteins in a non-sterol-modified form (Hh-
N*/Shh-N*). Autocatalytic processing of the full-length Hh
protein to the active N-terminal domain involves covalent linkage
to sterol [3,4]. How could cells generate non-sterol-modified Hh-
N*/Shh-N*? Hh-N*/Shh-N* might be generated enzymatically
by unknown sterol esterases or proteases, or cleavage of the
thioester bond by an alternative nucleophile. These proteins
cannot lack significant portions of the N-terminal signaling
domain; Hh-N*/Shh-N* are of slightly slower electrophoretic
mobility than their sterol-modified counterparts, migrating simi-
larly to Hh proteins from which cholesterol has been removed
either chemically or genetically [3]. This distinguishes Shh-N*
from Shh released by metalloprotease-mediated shedding, which is
a truncated protein with faster electrophoretic mobility than lipid
modified Shh [50]. Many studies have observed monomeric/
dimeric forms of secreted Hh proteins [8,11,51], although whether
these were sterol-modified was never established. This raises the
possibility that the autonomous ability of cells to release non-sterol-
modified forms is widespread.
Complementary Functions of Lipoprotein-Associated and
Non-Sterol-Modified Forms of Hh
The diversity of different forms of secreted Hh raises the
interesting issue of whether they might affect signaling in different
ways. For the first time, to our knowledge, we show here that at
least two of these different forms (lipoprotein-associated Hh and
Hh-N*) have qualitatively different effects on the Hh pathway. We
show that the lipoprotein-associated forms of both Drosophila Hh
and mammalian Shh can block the repressive effects of
lipoproteins on Hh signaling. In vivo experiments in Drosophila
reveal that lipoproteins and Lpp-associated Hh regulate a specific
subset of signaling events. Lpp-associated Hh can increase Smo
levels, partially phosphorylate Fused, and increase Ci155 levels.
However, Lpp-associated Hh cannot reduce levels of the Ci75
repressor form or activate expression of target genes. Non-sterol-
modified Hh-N* has a complementary function; extremely low
levels of Hh-N that do not affect signaling at all by themselves
combine with Lpp-associated Hh to complete Fused phosphory-
lation, reduce the levels of Ci75 repressor, and activate target gene
expression. Signaling experiments in Shh-LIGHT2 cells show that
lipoprotein-associated Shh can induce reporter transcription in
this assay; interestingly, it can also synergize with Shh-N* to
further increase pathway activity. Our findings in Drosophila
suggest it will be interesting to assay for different effects of each
Shh form on ciliary Smo trafficking and processing of Gli2 and
Gli3.
In general, it will be important to understand how these forms
act differently at the cellular level. We showed previously that Ptc
regulates Lpp trafficking and proposed that Ptc represses Smo, in
part by mobilizing an inhibitory lipid from Lpp particles [13].
Lipoprotein association may facilitate the access of Hh/Shh to this
compartment, allowing it to efficiently block mobilization of
lipoprotein lipids by Ptc. In contrast, non-lipoprotein-associated
Shh/Hh, although they likely bind to Ptc, may interact with
different co-receptors (e.g. Ihog and Cdo-family proteins, or
LRP2) with distinct signaling functions [52,53].
Much Hh research has focused on the importance of its graded
spatial and temporal distribution in patterning gene expression
[54,55]. Our data raise the possibility that tissue-patterning
information might be contained, not only in the absolute amount
of Hh but in the relative proportions of different Hh forms. These
forms may spread through tissue differently, form differently
shaped gradients, and interact with different receptor complexes.
Thus, the Hh activity gradient may reflect the superimposition of
gradients created by distinct Hh forms. In general, regulating the
secretion form of Hh might be one way of generating a diversity of
Hh responses in different tissues.
Materials and Methods
Mammalian Expression Plasmids
cDNA encoding human Shh in pCMV-XL5 vector was
purchased from OriGene (SC300021). ShhC24S, Shh-N, and
Shh-NC24S were generated by PCR.
Fly Stocks
The following stocks were used: lpp-GAL4 [56], en105-GAL4
[57], hh-GAL4, tub-GAL4, myoIA-GAL4 [58], npc1b-GAL4 [59],
the fat body. Error bars indicate 6 SEM (n= 20). *p,0.05; **p,0.005; ***p,0.0005; ****p,0.00005. (E–G) Quantification of (E) Hh, (F) Ci155, and (G)
Collier staining of wing discs shown in (H). Translucent lines indicate6 SD (n=12). (H) IF of wing discs from larvae secreting different combinations of
Hh and Hh-N from the fat body, stained for Hh, Ci155, and Collier. A denotes the anterior compartment, P the posterior compartment; yellow lines
indicate the compartment boundary. Scale bar = 50 mm.
doi:10.1371/journal.pbio.1001505.g006
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Figure 7. Signaling properties of lipoprotein-associated Shh and Shh-N* in Shh-LIGHT2 cells. (A, B) Concentration-dependent signaling
activity of (A) lipoprotein-associated Shh and (B) Shh-N*. Lipoprotein concentration in (A) was kept constant, and only the fraction carrying Shh
increased. Shh and Shh-N* levels used for signaling assays were assessed by WB. (C,D) Shh pathway activity in cells stimulated by Shh-N* in the
absence or presence of lipoproteins, or cells stimulated with lipoprotein-associated Shh. Lipoproteins, where added, were kept at a constant level. (C)
Mammalian lipoproteins, (D) Drosophila Lpp. (E) Synergistic signaling activity of Shh-N* and lipoprotein-associated Shh. Shh-N* and lipoprotein-
associated Shh were applied to cells alone or in combination. Predicted additive values represent the combined activity of lipoprotein-associated Shh
and Shh-N* in the presence of lipoproteins, minus the basal assay activity measured in unstimulated cells. Note that the same batch of samples was
used for assays shown in (A) and (B). For (A–E), error bars indicate 6 SD (n=3; **p,0.005; ***p,0.0005) of one representative experiment.
Experiments were repeated at least twice.
doi:10.1371/journal.pbio.1001505.g007
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hhts2, UAS-Hh [29], UAS-Hh-NLow, UAS-HhC85S, UAS-Hh-
NC85S [60], dispS037707 [25], wild type Oregon R, tub-GAL80TS,
dppLacZ, hs-flp (Bloomington), UAS-Dicer2, Cv-d RNAi (VDRC),
Lpp RNAi [12], LTP RNAi, and MTP RNAi [26].
UAS-Hh-NMed was generated by phiC31-mediated integration
of UAS-Hh-N into the VK33 attP landing site [61].
Antibodies
Antibodies used: Shh, Hh [57], apoLII, apoLI, Lpp [12,57],
Collier [62], Cv-d, apoLTPII [26], Ci 2A1 [63], Ptc, Smo, En,
Fused (DSHB), apoA1, apoB (Calbiochem), apoA1 (Abcam), a-
tubulin (Sigma), b-tubulin (Invitrogen), and b-Galactosidase
(Promega).
Human Lipoprotein Isolation
VLDL, LDL, and HDL were isolated from human serum
(Sigma) essentially according to [64]. Lipoproteins were applied to
HeLa cells at concentrations found in human serum.
Mammalian Cell Culture and Transfection
HeLa cells were grown in DMEM with 10% fetal bovine serum
(FBS, GIBCO), 50 U/ml penicillin, and 50 mg/ml streptomycin
(GIBCO).
HeLa cells were transfected with plasmids encoding Shh
variants using polyethylenimine (Polysciences) in OptiMem
(Invitrogen), then switched to experimental media 4 h after
posttransfection, and cultured for 48 h prior to sample collection.
To prepare Shh-N*, Shh-transfected HeLa cells were cultured
in serum-free media (DMEM+1% Insulin-Transferrin-Selenium
mixture (ITS-X, GIBCO)). Conditioned media were centrifuged
at 1,000 g, 20 min, then concentrated using Amicon Ultra 10K
(Millipore) for density gradient analysis and signaling assays.
Controls were identically treated media from nontransfected cells.
Note that centrifugation at higher speeds begins to pellet large
apoB-containing lipoproteins (Figure S12A).
To analyze association of Shh with lipoproteins, transfected
HeLa cells were cultured in DMEM supplemented with either
10% FBS, human lipoproteins (VLDL, LDL, or HDL in final
concentrations similar to those found in human serum), or
Drosophila larval hemolymph. Conditioned media were centrifuged
at 1,000 g, 20 min. Prior to density centrifugation, media were
concentrated using Amicon Ultra 10K. For signaling assays,
lipoprotein-associated Shh was isolated by density centrifugation
[65] and concentrated using Amicon Ultra 10K. Control
lipoproteins were prepared from identically treated media from
nontransfected HeLa.
MIA PaCa-2 cells (ATCCs) were grown in DMEM with 10%
FBS, 2.5% Horse Serum (Sigma), 50 U/ml penicillin, and 50 mg/
ml streptomycin. When confluent, cells were switched to DMEM
supplemented with 1% ITS and either VLDL, LDL, or HDL (in
final concentrations similar to those found in human serum) and
cultured for 48 h prior to sample collection. Conditioned media
were centrifuged at 1,000 g, 20 min, concentrated using Amicon
Ultra 10K, and analyzed by density gradient ultracentrifugation.
Cell lysates for Western blotting (WB) were prepared with
CelLytic M (Sigma) according to manufacturer instructions.
Expression of Fly Transgenes and RNAi
Hh variants were produced in the fat body using the UAS-
GAL4 system and the lpp-GAL4 driver. Lpp RNAi was induced as
described [12], using lpp-GAL4. Experiments were performed 4 d
after RNAi induction. Crosses were kept at 25uC. Because
continuous expression of Hh-NMed in the fat body causes larval
lethality, we temporally controlled expression of Hh variants in
experiments involving this construct using lpp-GAL4, tub-
GAL80TS at 29uC.
Hemolymph Isolation
Hemolymph was prepared as described [26]. Briefly, hemo-
lymph was collected from punctured third instar larvae in PBS,
centrifuged for 30 min at 1,000 g, then for 30 min at 16,000 g.
Note that higher centrifugation speeds pellet a large fraction of
hemolymph proteins (see Figure S12B). Isolation of Lpp on
preparative scales was performed as described [12].
Size and Density Fractionation of Hh Proteins
Isopycnic density centrifugation in Optiprep gradients (Frese-
nius Kabi) and KBr gradients was performed as described [12,57].
Proteins were separated according to size by gel filtration
chromatography on a Superdex 200 PC 3.2/30 column (GE
Healthcare). Running buffer: PBS, 0.001% NP-40. Fraction
volume: 50 ml. Size standards: Thyroglobulin (660 kDa), Ferritin
(450 kDa), Catalase (240 kDa), Ovalbumin (45 kDa), and Chy-
motrypsin (25 kDa).
Triton X-114 phase separation was performed essentially
according to [66]. Note that in these experiments, scaffolding
apolipoproteins partition into the aqueous phase, whereas
lipoprotein-associated, sterol-modified Hh proteins partition into
the detergent phase (see Figures 3H and S12C). This indicates that
the 1% Triton X-114 solutions used in these experiments suffice to
disassemble lipoprotein particles or extract lipid-modified proteins
from them.
Samples were precipitated with methanol/chloroform, separat-
ed on 15% polyacrylamide gels, and analyzed by WB.
Co-Immunoprecipitation
HeLa cells were transfected with either Shh or Shh-NC24S. At
4 h posttransfection, media were changed to DMEM+1% ITS
supplemented with either VLDL, LDL, or HDL (in final
concentrations similar to those found in human serum). Two days
later, media were collected and cleared by centrifugation at 1,000 g
for 20 min. Supernatants were diluted with Tris-HCL, pH 7.4, to
a final concentration of 50 mM Tris. Samples were incubated
overnight with Protein-G agarose (Roche) and antibodies targeting
apoB (Calbiochem) or apoA1 (Abcam). Beads were washed several
times with 50 mM Tris, pH 7.4+0.15 M NaCl, and precipitated
proteins subsequently analyzed by WB.
Radioactive Labeling
Labeling of Drosophila Hh with 3H-cholesterol was performed
essentially according to [4]. S2 cells stably expressing Hh [67] were
labeled for 24 h with 150 mCi [1,2,6,7-3H(N)]-cholesterol (Amer-
ican Radiolabeled Chemicals) in Schneider’s medium (GIBCO)
supplemented with 1% ITS and 1% FCS (Sigma). Supernatants
were centrifuged for 30 min at 1,000 g, then for 30 min at 16,000
g, and subsequently fractionated by KBr density gradient
centrifugation. Precipitated proteins of the different fractions were
analyzed both by WB and in-gel fluorography.
Purification of Hh-N* from Drosophila Imaginal Discs and
Embryos
Everted heads of wandering third instar larvae, from which all
organs except imaginal discs were removed, were used as a
relatively pure source of imaginal discs. Embryos were collected
for 12 h and subsequently dechorionated. Tissues were broken by
a loose douncer using buffer conditions as indicated for the
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different experiments (alkaline: 100 mM Na2CO3, pH 9; high salt:
10 mM Tris, pH 8+0.5 M NaCl). Note that the pH of the alkaline
buffer is too low to induce cleavage of the ester bond between
sterol and Hh (Figure S6C). Cells and large membrane fragments
were pelleted by centrifugation for 20 min at 1,000 g, and
subsequently for 20 min at 16,000 g. Small vesicles, exosomes, and
a large fraction of lipoproteins were pelleted by centrifugation for
2 h at 100,000 g. Resulting supernatants were fractionated by KBr
density gradient centrifugation. Indicated gradient fractions were
subsequently fractionated by gel filtration chromatography on a
Superdex 200 10/300 GL column (GE Healthcare). Running
buffer: PBS, 0.001% NP-40. Indicated fractions from density
gradients and sizing columns were further analyzed by Triton X-
114 phase separation. For experimental overview of Hh-N*
purification, see also Figures 4B and S7A.
Shh Activity Assay
Shh-LIGHT2 cells [33] were maintained in DMEM+10% FBS,
150 mg/ml zeocin (Invitrogen), and 400 mg/ml G418 (Invitrogen).
24 h prior to assay, cells were plated at 105/well in 96-well plates.
Cells were then switched to DMEM with 1% ITS-X and
supplemented with different combinations of Shh-N*, Lipopro-
tein-associated Shh, Lpp-associated Shh, bovine, or Drosophila
lipoproteins. Luciferase activity was assayed in cell lysates after
24 h, as instructed by the manufacturer (Dual Glo Luciferase
Assay, Promega).
Tissue Staining
Wing disc staining was performed as described [12].
Supporting Information
Figure S1 Shh is secreted in lipoprotein-associated and
lipoprotein-free forms. (A) Shh levels in cell lysates from HeLa
cells transfected with human Shh, grown in serum-free medium or
in the presence of 10% FBS, analyzed by Western blotting (WB).
(B) Density of different Shh lipid modification mutants. Superna-
tants from HeLa cells transfected with Shh, ShhC24S, Shh-N, or
Shh-NC24S and grown in the presence of FBS were analyzed by
Optiprep density gradient centrifugation and WB. Note that it is
difficult to determine whether palmitate might suffice for
lipoprotein association, since mammalian tissue culture cells
overexpressing Shh do not palmitoylate it efficiently [5,69]. (C)
WB of Shh secretion time course. HeLa cells were transfected with
Shh and grown in serum-free medium. 24 h after transfection,
medium was replaced by fresh medium supplemented with 10%
FBS; supernatants were collected after the indicated periods of
time, and equal volumes analyzed by Optiprep density gradient
centrifugation. Colors indicate fractions corresponding to bovine
Very Low-, Low-, and High-Density Lipoproteins (VLDL, LDL,
and HDL) [68]. (D) Immunoprecipitation of different human
lipoprotein classes from HeLa cell supernatants. ApoB was
detected by Coomassie staining of gels; apoA1 was detected by
WB. The same samples were analyzed for co-immunoprecipitated
Shh in Figure 1E.
(TIF)
Figure S2 Hh proteins can associate with different human and
Drosophila lipoproteins. (A) Shh levels in supernatants and cell
lysates derived from MIA PaCa-2, grown in serum-free medium
with or without addition of different human lipoproteins. Equal
amounts of cells (lysates) or volumes (supernatants) were analyzed
by WB. Compare the significantly higher amounts of Shh detected
in cell lysates of Shh-transfected HeLa cells. (B) Density of Shh and
apolipoproteins in MIA PaCa-2 cell supernatants shown in (A),
analyzed by Optiprep density gradient centrifugation. Gradients
were analyzed by WB to detect Shh (see also Figure 1G), and by
Commassie staining of gels to detect apolipoproteins. (C) Density
of Hh in supernatants from S2 cells expressing Drosophila Hh in
serum-free medium supplemented with Lpp, analyzed by
Optiprep density gradient centrifugation and WB. (D) Density of
Hh in supernatants of S2 cells expressing Drosophila Hh grown in
medium containing 10% FCS, analyzed by KBr density gradient
centrifugation and WB.
(TIF)
Figure S3 Properties of circulating Drosophila Hh and human
Shh. (A) Shh is present in lipoprotein-containing fractions in
human circulation. Lipoproteins were isolated from 4 ml of
human serum (Sigma) by KBr density centrifugation [65].
Membranous vesicles (along with large lipoproteins such as
chylomicrons and VLDL—see also Figure S12A) were pelleted
by centrifugation at 100,000 g for 2 h, and resulting supernatants
subsequently analyzed by Optiprep density gradient centrifugation
and WB. Colors indicate fractions corresponding to human Very
Low-, Low-, and High-Density Lipoproteins (VLDL, LDL, and
HDL) [43]. (B) Hemolymph Hh levels in larvae expressing Hh
RNAi in imaginal discs (hh-GAL4) or ubiquitously (tubulin-GAL4).
Hh knock-down in imaginal discs does not reduce the levels of
hemolymph Hh. In contrast ubiquitous knock-down strongly
depletes Hh from the hemolymph. (C) Hh RT-PCR on cDNA
prepared from total RNA extracts from larval fat body (without
gonads) and wing discs. Actin was used as a positive control. The
actin primers were designed to span an intron to allow detection of
possible contamination of cDNA preparations with genomic DNA.
Note that Hh transcripts can be detected in the wing disc, but not
in the larval fat body. (D) Density of hemolymph Hh and
lipoproteins, analyzed by KBr density gradient centrifugation and
WB. Note that Drosophila lipoproteins are separated more
completely in these KBr gradients than in Optiprep gradients
(compare Figure S3G). (E) Density of hemolymph Hh from
normally fed or lipid-starved larvae, analyzed by Optiprep density
gradient centrifugation and WB. Note that lipid-starvation
increases the density of Lpp [26]. (F) Hydrophobicity of
hemolymph Hh from normally fed or lipid-starved larvae,
analyzed by Triton X-114 phase separation and WB. Note that
removal of lipids (including sterols) from the diet does not alter Hh
hydrophobicity. (G) Density of hemolymph Hh of wild-type and
Lpp RNAi larvae, analyzed by Optiprep density gradient
centrifugation and WB. Lpp RNAi causes the appearance of a
population of hemolymph Hh that has a higher density than any
Drosophila lipoprotein. Note that Lpp is by far the most abundant
lipoprotein in Drosophila larvae [26].
(TIF)
Figure S4 The Drosophila hemolymph as a system to study Hh
secretion. (A) Hemolymph Hh levels in larvae expressing Hh
under the control of different GAL4 drivers, analyzed by WB. lpp-
GAL4 is strongly active in the fat body; myoIA-GAL4 is mostly and
strongly active in the gut; npc1b-GAL4 is moderately active in the
midgut; en105-GAL4 is mostly and strongly active in the posterior
compartment of imaginal discs. Cv-d is used as a loading control.
(B) Hh levels in hemolymph and fat body of control and
Dispatched (Disp) mutant larvae ectopically expressing Hh in
the fat body, analyzed by WB. Note that hemolymph levels of fat-
body-secreted Hh are strongly decreased in Dispatched mutants.
Loading controls are Cv-d (hemolymph) or tubulin (larval extract).
(C) Hh levels in hemolymph and gut of control and Dispatched
mutant larvae ectopically expressing Hh in the midgut. Note that
hemolymph levels of midgut-secreted Hh are strongly decreased in
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Dispatched mutants. Loading controls are Cv-d (hemolymph) or
tubulin (larval extract). (D) Density of hemolymph Hh in larvae
expressing Hh under the control of lpp-GAL4 (see also Figure 3B),
npc1b-GAL4, or en105-GAL4 (see also Figure S1E), analyzed by
Optiprep density gradient centrifugation and WB. Note that
different amounts of hemolymph were analyzed for the different
GAL4 lines; for absolute levels of hemolymph Hh under these
conditions, see (A). (E) WB of Hh secretion time course. Hh was
expressed in the fat body in a time-controlled manner using lpp-
GAL4, tubulin-GAL80TS. Hemolymph was collected after the
indicated periods of time, and equal amounts fractionated in
Optiprep density gradients. (F) Immunofluorescence of fat body
and wing disc from larvae expressing UAS-CD8-GFP with lpp-
GAL4. Membranes are stained with FM-4-6-4. GFP can be
readily detected in the fat body, but not in the wing disc. Scale
bar = 50 mm. (G) Hemolymph Hh levels in larvae expressing Hh
lipid modification variants in the fat body. Note that ectopic of any
Hh variant strongly elevates hemolymph Hh levels compared to
wild type. Loading control is apoLTPII.
(TIF)
Figure S5 Molecular properties of different Hh/Shh secretion
forms. (A) WB of Shh fractionated by size and density.
Supernatants from Shh-transfected HeLa cells grown in the
presence of FBS were analyzed by gel filtration chromatography.
Column fractions were pooled as indicated and subsequently
analyzed by both Triton-X 114 phase separation and Optiprep
density gradient centrifugation. (B) WB of hemolymph Hh
fractionated by size and density. Fat-body-secreted hemolymph
Hh was analyzed by gel filtration chromatography. Column
fractions were pooled as indicated, and subsequently analyzed by
Optiprep density gradient centrifugation. (C) Quantification of the
elution profiles of hemolymph Hh secreted from wild-type and
Lpp RNAi fat bodies (see Figure 3D). Hh band intensity in each
fraction is depicted as percentage of the combined Hh signal of all
column fractions. (D) Hydrophobicity of Shh lipid modification
mutants. Different Shh mutants were expressed in HeLa cells
grown in serum-containing medium, and resulting supernatants
analyzed by Triton X-114 phase separation and WB. (E)
Hydrophobicity of Hh lipid modification mutants. Different Hh
variants were secreted to the hemolymph from the fat body, and
their hydrophobicity assessed by Triton X-114 phase separation.
Sterol-modified Hh/Shh and HhC85S/ShhC24S partition predom-
inantly into the detergent (det) phase. Hh variants lacking sterol
modification (Hh-N/Shh-N and Hh-NC85S/Shh-NC24S) partition
predominantly into the aqueous phase (aq). (F) Hydrophobicity
and electrophoretic mobility of Hh, Hh-N*, and Hh-NC85S,
assessed by Triton X-114 phase separation and WB. Note the
similar electrophoretic mobility of aqueous phase Hh-N* and Hh-
NC85S. See also Figure 3H,I.
(TIF)
Figure S6 Lipoprotein-independent Hh secretion forms in
imaginal discs. (A and B) Quantification of (A) Ci155 and (B)
Engrailed staining of wing discs from larvae in which Lpp, LTP, or
Cv-d was knocked down in the fat body by RNAi. Lpp RNAi
stabilizes Ci155 throughout the anterior compartment (see also
Figure 5B,D) and reduces the range of Engrailed expression close
to the compartment boundary. LTP or Cv-d RNAi does not
detectably affect Hh signaling. Yellow lines indicate the anterior/
posterior compartment boundary. Translucent lines indicate 6SD
(n=10). (C) Hemolymph from larvae secreting Hh from the fat
body was diluted 1:10 with PBS, 100 mM Na2CO3 pH 9, or
100 mM Na2CO3 pH 10 and incubated for 24 h. Subsequently,
Hh hydrophobicity was analyzed by Triton X-114 phase
separation and WB. pH 9 or pH 10 does not increase the levels
of Hh present in the aqueous phase, indicating that these
conditions do not hydrolyze the ester bond between Hh and
sterol. (D) Effect of mildly alkaline pH or high salt on the recovery
of high-density Hh from Drosophila imaginal discs. The 100,000 g
supernatants were subjected to KBr density gradient centrifuga-
tion and gradient fractions analyzed by WB. The same number of
everted heads was processed for each gradient. Note that high-
density Hh is completely undetectable in 100,000 g supernatants of
imaginal discs dissociated in PBS.
(TIF)
Figure S7 Drosophila embryos produce Hh-N*. (A) Experimental
scheme to purify Hh-N* from Drosophila embryos. Embryonic
extracts for experiments shown in (B–F) were prepared with
100 mM Na2CO3, pH 9. Embryonic extracts for experiments
shown in (H) and (I) were prepared in 10 mM Tris-HCl, pH 8, 0.5
M NaCl. All buffers used for preparation of embryonic extracts
contained 0.05% NP-40. (B) Recovery of Hh in 16,000 g (S1) and
100,000 g (S2) supernatants from embryonic extracts, analyzed by
WB. Equivalent amounts of S1 and S2 were loaded. (C) Density of
soluble Hh in S2 from embryonic extracts, analyzed by KBr
density gradient centrifugation and WB. (D) Hydrophobicity of
low-density and high-density Hh from (C), assessed by Triton X-
114 phase separation. (E) Size of low-density and high-density Hh
from (C), assessed by gel filtration chromatography and WB. (F)
Hydrophobicity of high-density/low-molecular-weight Hh from
(E), assessed by Triton X-114 phase separation. (G) Effect of high
salt on the recovery of high-density Hh from Drosophila embryos.
The 100,000 g supernatants were fractionated in KBr density
gradients and analyzed by WB. Similar volumes of embryos were
processed for each gradient. Gradients showing extracts prepared
with PBS 60.5 M NaCl were analyzed in the same experiment;
extracts prepared with 10 mM Tris-HCl, pH 8, 0.5 M NaCl were
processed and analyzed separately. (H) Hydrophobicity of low-
density and high-density Hh recovered by high salt conditions
shown in (G), assessed by Triton X-114 phase separation and WB.
(I) Size of high-density Hh recovered by high salt conditions,
assessed by gel filtration chromatography and WB.
(TIF)
Figure S8 Effects of hemolymph Lpp-associated Hh and Lpp
RNAi on Hh signaling in the wing imaginal disc. (A) Wing discs
from larvae secreting moderate levels of Hh into the hemolymph
under the control of npc1b-GAL4 or high levels under the control
of lpp-GAL4, stained for Hh and Ci155 (see also Figure S3A). npc1b-
GAL4 does not drive sufficient Hh expression to influence
signaling in the disc. We expect therefore that the much lower
endogenous levels of circulating Hh are insufficient to influence
patterning in discs. Furthermore, en105-GAL4 produces even less
circulating Hh than npc1b-GAL4 (see Figure 4A). Thus, the small
increase in circulating Hh caused by en105-GAL4–driven Hh
expression is unlikely to contribute to increased Hh signaling in
en105-GAL4.UAS Hh wing discs. Scale bar = 50 mm. (B and C)
Quantification of (B) Hh, (C) Ci155, staining of wing discs shown in
(A). Yellow lines indicate the anterior/posterior compartment
boundary. Translucent lines indicate 6SD (n=10). (D) Quanti-
fication of Smoothened staining in wing discs from larvae secreting
Hh from the fat body. Note that Lpp-associated Hh secreted from
the fat body increases Smoothened levels in the anterior
compartment. Yellow lines indicate the anterior/posterior com-
partment boundary. Translucent lines indicate 6SD (n=10). (E)
Quantification of Ci75 levels in wing discs from larvae expressing
Hh or Lpp RNAi in the fat body. Band intensity of Western blots
was quantified and normalized to a-tubulin. Error bars indicate
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6SD (n=5). (F) Quantification of Engrailed in wing discs from
Lpp RNAi larvae or larvae secreting Hh from the fat body. Note
that expression of the high-threshold Hh target gene Engrailed is
strongly repressed in the wing disc by high levels of Lpp-associated
Hh. Yellow lines indicate the anterior/posterior compartment
boundary. Translucent lines indicate 6SD (n=12). (G) Immuno-
fluorescence of wing discs from Lpp RNAi larvae or larvae
secreting Hh from the fat body, stained for Hh, Ci155, and
Engrailed. Scale bar = 20 mm.
(TIF)
Figure S9 Signaling properties of Hh-N*. (A) Immunofluores-
cence of wing discs from larvae secreting Hh or Hh-N* from the
fat body, stained for Hh and Ci155. Hh-N* was generated by
expressing Hh in the fat body of Lpp RNAi animals. Scale
bar = 100 mm. (B) Quantification of Hh staining of wing discs
shown in (A). Yellow lines indicate the anterior/posterior
compartment boundary. Translucent lines indicate 6SD (n=10).
(TIF)
Figure S10 Signaling properties of Hh-N. (A) Immunofluores-
cence of wing discs from larvae secreting Hh or Hh-NMed from the
fat body, stained for Hh, Ci155, and Engrailed. Scale bar = 50 mm.
(B–D) Quantification of (B) Hh, (C) Ci155, and (D) Engrailed
staining of wing discs shown in (A). Translucent lines indicate
6SD (n=12). (E) Quantification of Ci75 levels in wing discs from
larvae expressing Hh or Hh-NMed in the fat body. Band intensity
of Western blots was quantified and normalized to a-tubulin.
Error bars indicate 6SD (n=3); *p,0.05. (F) Quantification of
Ci75 levels in wing discs from larvae expressing Hh and Hh-N
Low,
alone or in combination, in the fat body. Band intensity of Western
blots was quantified and normalized to a-tubulin. Error bars
indicate 6SD (n=5); *p,0.05. (G) Immunofluorescence of wing
discs from larvae secreting Hh and Hh-NLow, alone or in
combination, from the fat body, stained for Hh, Ci155, and
dppLacZ. Scale bar = 50 mm.
(TIF)
Figure S11 Lipoproteins repress the signaling activity of Shh-
N*. (A) Shh-N* isolated from HeLa cells grown in serum-free
medium was incubated in PBS containing 1% FBS at 37uC with
constant shaking and subsequently fractionated by density
gradient centrifugation. Shh-N* that was not exposed to serum
served as a control. After incubation with serum, the vast majority
of Shh-N* was still present in fractions of the highest density,
suggesting that it failed to associate with lipoproteins. (B)
Concentration-dependent repression of signaling activity of Shh-
N* by lipoproteins in Shh-LIGHT2 cells. The concentration of
lipoprotein-associated Shh or Shh-N* was kept constant, and only
the amount of lipoproteins increased. Note that the starting
amount of lipoproteins in the case of lipoprotein-associated Shh
already corresponds to 10 arbitrary units. Error bars indicate6SD
(n=3; *p,0.05, **p,0.005, ***p,0.0005). Shown is one repre-
sentative experiment out of three.
(TIF)
Figure S12 Ultracentrifuge sedimentation and Triton X-114
phase separation behavior of lipoproteins and Hh proteins. (A)
Different human lipoprotein classes isolated from human serum
were centrifuged at 100,000 g for 2 h. Equal volumes of input and
100,000 g supernatants (S) were separated by gel electrophoresis
and visualized by Coomassie staining. Note that centrifugation at
100,000 g completely pellets VLDL and partially pellets LDL
particles. HDL levels in 100,000 g supernatants are not
significantly affected compared to input samples. (B) Drosophila
larval hemolymph was centrifuged at the indicated speeds;
resulting pellets and supernatants were analyzed by WB. The
Lpp scaffolding protein apoLI was visualized by Ponceau S
staining of the nitrocellulose membrane, the LTP scaffolding
protein apoLTPII by immunodetection. Note that all detectable
LTP and a large fraction of the smaller Lpp are pelleted by
centrifugation at 100,000 g. (C) Lipoproteins isolated from FBS
were subjected to Triton X-114 phase separation, alone or after
mixing with Shh-N*. Note that both the HDL scaffolding
apolipoprotein apoA1 and Shh-N* partition into the aqueous
phase. Similarly, Shh-N* partitions into the aqueous phase in the
absence of lipoproteins (see Figure 3G).
(TIF)
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